Entecavir Exhibits Inhibitory Activity against Human Immunodeficiency Virus under Conditions of Reduced Viral Challenge

Entecavir (ETV) was developed for the treatment of chronic hepatitis B virus (HBV) infection and is globally approved for that indication. Initial preclinical studies indicated that ETV had no significant activity against human immunodeficiency virus type 1 (HIV-1) in cultured cell lines at physiolo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lin, Pin-Fang, Nowicka-Sans, Beata, Terry, Brian, Zhang, Sharon, Wang, Chunfu, Fan, Li, Dicker, Ira, Gali, Volodymyr, Higley, Helen, Parkin, Neil, Tenney, Daniel, Krystal, Mark, Colonno, Richard
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 2008
Konular:
Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2346618/
https://ncbi.nlm.nih.gov/pubmed/18316521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01313-07
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller